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Traumatic thoracic aortic injury and ruptures
Girma Tefera, MD, Madison, WiscDescending thoracic aortic injury (DTAI) is the most
frequent cause of death at the site of severe motor vehicle
crash and is associated with deceleration injury.1 Although
the incidence of DTAI is low (18% of motor vehicle acci-
dents),2 it is the second most common cause of trauma-
related death3 and represents 1% of trauma admissions to
the hospital. It has been estimated that over 80% DTAI
patients die at the scene.1,4-8 For those patients who arrive
alive to the hospital, the estimated mortality rate is 32%,
with one-third of those patients dying before operative
intervention.5,7,9 In those who survive the injury, even after
controlling for associated injuries, the presence of DTAI in
multiple trauma patients impacts negatively on survival and
results in poor long-term function following discharge.10
Fabian et al report that untreated aortic injury carries a
mortality rate of up to 85%.6 This mandates a timely
diagnosis and treatment. Computed tomographic angiog-
raphy (CTA) can provide accurate and early diagnosis
within minutes, however, high index of suspension based
on the mechanism of injury is critical to initiate the work-
up. CTA is the imaging modality of choice to evaluate
aortic injuries, and it has replaced conventional contrast
arteriography. CTA can be completed within minutes, with
an excellent accuracy and be used for device selection;
however, pitfalls of underestimating aortic diameter in pa-
tients who have been under resuscitated should be kept in
mind. Intravascular ultrasound (IVUS) following fluid re-
suscitationmay provide accurate reading.11 In patients with
multiple traumas, delay in the diagnosis of aortic tear can
have a fatal outcome; however, in some patients with
multiple life-threatening injuries, the definitive treatment
of a stable aortic repair can be delayed.12 In our series, half
of the patients were treated in a delayed fashion.13 The use
of beta-blockers to lower heart rate and the use of vasodi-
lator to lower blood pressure were adequate.
Despite lack of level I evidence, open repair is falling
out of favor as the gold standard. In recent years, endovas-
cular thoracic endovascular aneurysm repair (TEVAR) ap-
proach has been advocated by several authors. In fact, in a
recent review by Jonker of all patients in the state of New
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Open surgical repair is performed with either a primary
anastomosis or interposition graft. This can be accom-
plished with clamp-and-sew technique or with additional
circulatory assistance.15 The mortality rate following open
surgical repair is about 20%, and this rate of mortality for
open repair did not change over the past several decades.
Morbidity rates particularly paraplegia secondary to spinal
cord ischemia is also as high as 14%.1,10
At our institution, open surgical repair is performed
utilizing the clamp-and-sew technique. However, spinal
cord protection adjuncts are used whenever possible.15
These include cerebrospinal fluid drainage, Naloxone ad-
ministration, and moderate hypothermia. In a prospective
study of DTAI, aortic cross clamp time beyond 30 minutes
is associated with paraplegia and bypass techniques, which
provide distal aortic perfusion, produced significantly lower
paraplegia rates than the clamp-and-sew approach.6 Open
surgical repair for aortic injuries can be very challenging, as
up to 70% of patients will have severe associated injuries
such as pulmonary contusions requiring high positive pres-
sure ventilation, head injury, splenic injury, and pelvic
fractures. The elderly with coronary artery disease are also
at higher risk as they may not well tolerate aortic cross
clamping during an open repair.
ENDOGRAFT REPAIR AND LIMITATIONS
The perceived advantages of TEVAR are very clear. It is
less invasive and does not require thoracotomy and aortic
cross clamping. This procedure can be performed percuta-
neously under local anesthesia. However, in the United
States, there is no FDA approved device for the treatment
of DTAI and this has led to the off label use of stent grafts.
TEVAR procedure has some limitations.
(1) Smaller device diameters are not available for use in
younger patients with small aorta. Several authors have
reported the off label use of infrarenal aortic extension
cuffs; however, aortic diameters of less than 20 mm still
pose a challenge. The relatively short delivery catheter
length limits its wider use. Access site complications up to
7% have also been reported.16
(2) The ideal length of stent graft for treatment of
DTAI is probably 5 to 7 cm in length. Most of the thoracic
devices are / 10 cm, hence, unnecessarily covering
longer health aortic wall. However, Fattori et al report that
the paraplegia and paraparesis rates to be related to over 20
cm length coverage of the thoracic aorta.17
(3) Most of the currently available devices are rigid and
do not conform well to the inner curvature of the aortic
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lapse of stent graft following an oversized nonconforming
deployment.18 A nonrandomized registry for the new con-
formable C-TAG device is under way to evaluate the safety
and efficacy of the device in DTAI.
(4) Graft deployment and fixation mechanism need to
be improved to the authors’ knowledge that there is no case
of graft migration reported following TEVAR for DTAI.
However, in the hyperdynamic aortic arch and descending
thoracic aorta, a precise deployment can be challenging.
(5) Because of the proximity of these injuries to the left
subclavian artery, the left subclavian artery orifice has to
often be covered, transposed, or bypassed.3,19 Coverage of
the left subclavian artery orifice is reported to be associated
with a fourfold increase spinal cord ischemia resulting in
paraplegia,20 stroke, and upper extremity ischemia. In a
meta-analysis by Dunning et al, 498 patients from 20
different studies left SCA coverage without revasculariza-
tion caused symptoms of upper extremity ischemia in 10%
of the patients and in only 4% were these symptoms signif-
icant enough to warrant intervention.21
Endovascular infrarenal aortic repair was introduced in
1991 by Parodi.22 Since then this technique has been
significantly refined, the treatment of thoracic aortic aneu-
rysm, aortic dissection, and repair of traumatic thoracic
aortic injuries has become common clinical practice. There
are three FDA approved stent grafts for thoracic aortic
aneurysm treatment. In clinical trials, all three devices have
shown clinical utility and safety in the treatment of de-
scending thoracic aortic aneurysms. With further design
improvements, their applications and use will continue to
expand and collectively these three devises cover aortic
diameters ranging from 22 mm to 46 mm.
It is conceivable that the absence of aortic occlusion
during endovascular repair may result in less incidence of
paraplegia, overall mortality, and morbidity. In the litera-
ture, while paraplegia has been associated with degenera-
tive thoracic aneurysm repairs with TEVAR,23-25 there
have been only a few cases reported in the context of DTAI.
More recently, Cambria et al reported that one of the 20
patients treated for DTAI with stent graft developed para-
plegia. In this patient both the left subclavian and vertebral
artery orifices were intentionally covered,18 and one other
reported case resulted in paraplegia due to stent collapse
and thoracic aortic thrombosis.26 In this same study, mor-
tality rate for TEVAR was 23% for open repair and 7.2% for
TEVAR.
At the present time, there are no FDA-approved de-
vices for endovascular treatment of DTAI; however, several
case reports and case series of successful endovascular repair
of DTAI with homemade devices27,28 with stalking multi-
ple commercially available abdominal aortic extension cuffs
and with currently available thoracic endoprosthesis are
available (Table I).29,30 In a recent report by Rosenthal et
al, all 31 patients treated with stent-graft cuffs successfully
excluded the injury site: 21 patients had 2 cuffs, 9 had 3
cuffs, and 1 had 4 cuffs. The aorta adjacent to the injury
mean diameter was 18.5 mm (range, 17-24 mm). Nosubclavian arteries were covered; however, two patients
required an additional cuff for exclusion of the type I
endoleaks at the distal attachment site within 6 weeks of
initial endograft repair. There were no procedure-related
deaths.28 However, the disadvantage of using abdominal
aortic extension cuffs is the inadequacy of the delivery
catheter length. The Gore Excluder (W. L. Gore & Asso-
ciates, Flagstaff, Ariz) graft delivery catheter is 61 cm while
the AneuRx cuff (Medtronic, Santa Rosa, Calif) is 55 cm.
In most instances, this may require retroperitoneal com-
mon iliac artery access to deliver the stents in place. Simi-
larly, in the report on three consecutive cases by Sam, the
injury site was excluded in all three patients using commer-
cially available AnueRx and Gore Excluder aortic extension
cuffs without any significant morbidity and mortality.30
Fujikawa reported on six consecutive cases treated with
homemade endografts. All of his patients had other associ-
ated injuries with a mean injury severity score of 36. These
repairs were done with minimal blood loss and short oper-
ative time. Five of the six patients did well with the com-
plete resolution of periaortic hematoma within 2 weeks
and, most importantly, there were no stent related compli-
cations.29
In a multicenter clinical trial of endovascular stent graft
repair of acute catastrophes of the descending thoracic
aorta using the Gore TAG device, Cambria et al confirmed
the advantages of TEVAR in reducing morbidity and mor-
tality over open repair. Of the 20 patients treated with
TEVAR following aortic injuries, only one patient devel-
oped paraplegia and one died from respiratory failure due
to pulmonary contusions. In this study, subclavian artery
coverage was associated with the single case of paraplegia.18
Paraplegia following TEVAR for trauma is very rare. Prior
to this report by Cambria et al, there are only two other
cases of paraplegia reported in the literature.
In a recent report from our institution, between the
years 1999 and 2007, 26 patients (14 TEVAR and 12
open) were treated for ADTI. The mechanism of injury was
primarily motor vehicle accidents (92%). The mean age in
the open group was 33 (12-78) and 39 (17-82) in the
endovascular groups. Most patients were male (20/26),
with 10males in each group. The average time to repair was
0.3 days (range 0-1) for the open group and 12.2 days
(0-141) in the endovascular group. Nine of the 14 endo-
Table I. Outcomes for DTAI review
Author
No. of
patients Death Paraplegia Graft used
Rosenthal 31 0 0 Cuff
Jones 11
Fujikawa 6 0 0 Home made
Sam 3 0 0 Cuff
Cambria 20 1 1 TAG
Yamne 14 1 0 Cuff/ TAG
DTAI, Descending thoracic aortic injury.vascular patients required placement of multiple stents. All
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cuffs. Five other patients were treated with commercially
available thoracic endografts. The left subclavian artery
orifice was partially or completely covered in four patients
in the TEVAR group. None of these patients had any
residual left upper extremity ischemia, weakness, pain, or
stroke. There was no case of renal failure postoperatively in
any patient in either group. One patient in the endovascular
group was paraplegic secondary to a T11-12 fracture and
dislocation with a retropulsed disk fragment in the spinal
canal and, therefore, was not included as a paraplegic
complication of vascular repair. Otherwise, there were no
postoperative paraplegias.
When TEVAR was compared with open repair, no
significant difference was noted between the groups with
regard to intraoperative or total blood product administra-
tion. There was a statistically significant difference between
groups in the amount of intraoperative fresh frozen plasma
that was administered, with the open group being higher
with a mean of 6.6 units and the TEVAR group receiving
1.6 units (P  .05). The other significant difference was in
preoperative creatinine levels, with the open group being
significantly lower at 0.99 vs 1.26 in the endovascular
group.
Similarly, two patients in TEVAR group and one in the
open group had complications requiring reintervention.
While there was no significant difference in morbidity or
mortality between the two treatment groups, one can infer
that in the short-term follow-up, TEVAR repair is as safe as
open repair for DTAI and can be safely used in the anatom-
ically appropriate patient.
STENT GRAFT FOR RUPTURED
THORACIC AORTA
All the possible advantages of TEVAR discussed above
apply for this acute aortic catastrophe. The contemporary
reports indicate that mortality rate from open surgical
repair of ruptured thoracic aortic aneurysm is high.31 In a
retrospective review from a single institution from 1996 to
2006, Barbato reports that the perioperative mortality rate
for open repair was 26.8%.Most deaths occurred in the first
24 hours. Reports on TEVAR for ruptured thoracic aneu-
rysm, however, indicate a much favorable mortality and
paraplegia rates (Table II).18,32,33 This result is similar to
the results outlined in the meta-analysis by Jonker where
preoperative mortality and paraplegia rates were signifi-
Table II. Outcomes of TEVAR for ruptured thoracic
aortic aneurysm
Author
No. of
patients
Technical
success
Mortality
rate
Paraplegia
rate
Scheinert 21 100 14.3 0
Cambria 20 100 11.4 0
Patel 33 94 11.4 1.4
TEVAR, Thoracic endovascular aneurysm repair.cantly lower in the TEVAR group, 19% vs 33% and 3.1%and 5.5% for TEVAR and open repair, respectively. The
long-term follow-up seems to be unfavorable for TEVAR
as there are more aneurysm related mortalities.14
CONCLUSION
TEVAR is clearly becoming the treatment of choice in
patients with DTAI and ruptured thoracic aneurysm.
Those patients with DTAI and have multiple other life
threatening injuries or elderly trauma patients with an
increased cardiovascular risk can benefit the most. There is
an urgent need for the development of the ideal thoracic stent
graft for trauma and amulticenter clinical trial to compare the
results of this novel technique with the standard open surgi-
cal repair. Long-term follow-up of patients who underwent
stent graft treatment is critical to assess and treat failures.26
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